Potassium Sparing Diuretics: Why "Primary Hyperaldosteronism" Screening is Suddenly a Major Market Force?
For a long time, the condition known as Primary Hyperaldosteronism (a hormonal cause of high blood pressure) was considered rare, but 2026 research has revealed that it may affect up to 10% of all hypertension patients. This realization has sparked a global "Screening Revolution," where potassium-sparing diuretics—specifically aldosterone antagonists—are being recognized as the only...
0 Comments 0 Shares 12 Views 0 Reviews